Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-26

Clinical Trial Update: The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of the Xue-Fu-Zhu-Yu Capsule for Qi Stagnation and Blood Stasis Syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xue-Fu-Zhu-Yu Capsule

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Qi Stagnation and Blood Stasis Syndrome | Phase 2 | Status: COMPLETED